Table 1 Baseline characteristics of nursing home residents in the cohort
Total (n = 76) | JJP VA (n = 46) | JHL (N = 30) | |
|---|---|---|---|
Age (mean (SD)) | 74.4 (11.9) | 69.4 (10.8) | 82.0 (9.4) |
Female | 31.6 | 2.2 | 76.7 |
Race | |||
White | 57.9 | 45.7 | 76.7 |
Black | 29.0 | 43.5 | 6.7 |
Hispanic | 11.8 | 10.9 | 13.3 |
Comorbid Conditions (%) | |||
CHF | 25.0 | 17.4 | 36.7 |
COPD | 27.6 | 32.6 | 20.0 |
Stroke | 15.8 | 15.2 | 16.7 |
Dementia | 40.8 | 21.7 | 70.0 |
Depression | 38.2 | 37.0 | 26.7 |
Falls | 52.6 | 41.3 | 70.0 |
Medications (total no. ± SD) | 7.6 ± 3.2 | 8.0 ± 3.6 | 6.8 ± 2.6 |
CNS Medications (%) | |||
Antidepressants | 25 | 22 | 30 |
Anti-psychotic medications | 17 | 17 | 17 |
Opioids | 33 | 30 | 37 |
Any combination of 2 or more | 25 | 30 | 16 |
Duration of NH residence (Median, Inter Quartile Range) | 153 (55,563) | 74 (36, 233) | 250 (107, 729) |
Number of hospitalization in the year prior to enrollment ± SD | 1.2 ± 1.1 | 1.5 ± 1.2 | 0.7 ± 0.5 |
Number of acute illness episodes (per resident per year) | 1.5 ± 2.0 | 1.7 ± 2.2 | 1.0 ± 1.3 |
Function (MDS-ADL) | 2.3 ± 2.1 | 2.2 ± 2.3 | 2.4 ± 2.0 |
Cognitive function (MDS-CPS) | 1.1 ± 1.6 | 1.0 ± 1.8 | 1.3 ± 1.5 |
Depression (GDS-15) | 5.2 ± 4.4 | 5.5 ± 4.4 | 4.8 ± 4.5 |
Pain (0-10 scale) | 4.7 ± 3.6 | 5.5 ± 3.3 | 3.4 ± 3.7 |
Psychosis and disturbed behavior (CMAI) | 35.8 ± 8.1 | 35.9 ± 7.9 | 35.7 ± 8.6 |